Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia

The findings suggest that valbenazine may be used effectively and safely as a treatment for TD, even in elderly patients.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Psychopharmacology
Published
2024-08-26
DOI
https://doi.org/10.1097/jcp.0000000000001903
Citations
1
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia

Hideaki Masui, Nobuhisa Kanahara, Yutaka Susuta, Yumi Watanabe et al.
1 citations
Journal of Clinical Psychopharmacology
Parkinson's Disease Mechanisms and Treatments
0.37
article

Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia

Hideaki Masui, Nobuhisa Kanahara, Yutaka Susuta, Yumi Watanabe, Mieko Nagano
article en
1 citations

Abstract

The findings suggest that valbenazine may be used effectively and safely as a treatment for TD, even in elderly patients.

Journal of Clinical PsychopharmacologyVol. 44(6)
Mitsubishi Group (Japan) (JP), Center for Forensic Mental Health, Chiba University (JP), Tanabe Research Laboratories (US), Mitsubishi Tanabe Pharma Corporation
Good health and well-being
Openalex Percentile: Top 36%
Parkinson's Disease Mechanisms and Treatments
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.